Viral Inactivation - Global Market Outlook (2017-2023)

SKU ID :SMRC-10733617 | Published Date: 01-Oct-2017 | No. of pages: 191
1 Executive Summary 2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining 2.4.2 Data Analysis 2.4.3 Data Validation 2.4.4 Research Approach 2.5 Research Sources 2.5.1 Primary Research Sources 2.5.2 Secondary Research Sources 2.5.3 Assumptions 3 Market Trend Analysis 3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 Application Analysis 3.7 Product Analysis 3.8 End User Analysis 3.9 Emerging Markets 3.10 Futuristic Market Scenario 4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Viral Inactivation Market, By Application 5.1 Introduction 5.2 Stem cell products 5.3 Cellular & Gene therapy products 5.4 Blood & Blood tissue products 5.5 Vaccines & Therapeutics 5.6 Tissues & Tissue products 6 Global Viral Inactivation Market, By Product 6.1 Introduction 6.2 Viral inactivation accessories 6.3 Systems and Services 6.4 Kits & Reagents 7 Global Viral Inactivation Market, By Method 7.1 Introduction 7.2 pH Concentration method 7.3 Alkylating agent method 7.4 Solvent detergent method 7.5 Pasteurization 7.6 Radiation method 7.7 Other Methods 8 Global Viral Inactivation Market, By End User 8.1 Introduction 8.2 Blood banks and Hospitals 8.3 Academic research institutes 8.4 Pharmaceutical and Biotechnology companies 8.5 Contract Research Organizations 8.6 Other End Users 9 Global Viral Inactivation Market, By Geography 9.1 Introduction 9.2 North America 9.2.1 US 9.2.2 Canada 9.2.3 Mexico 9.3 Europe 9.3.1 Germany 9.3.2 U.K 9.3.3 France 9.3.4 Italy 9.3.5 Spain 9.3.6 Rest of Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Australia 9.4.5 New Zealand 9.4.6 South Korea 9.4.7 Rest of Asia Pacific 9.5 South America 9.5.1 Argentina 9.5.2 Brazil 9.5.3 Chile 9.5.4 Rest of South America 9.6 Middle East & Africa 9.6.1 Saudi Arabia 9.6.2 UAE 9.6.3 Qatar 9.6.4 South Africa 9.6.5 Rest of Middle East & Africa 10 Key Developments 10.1 Agreements, Partnerships, Collaborations and Joint Ventures 10.2 Acquisitions & Mergers 10.3 New Product Launch 10.4 Expansions 10.5 Other Key Strategies 11 Company Profiling 11.1 Macopharma SA 11.2 Charles River Laboratories International, Inc. 11.3 Clean Cells Inc. 11.4 Danaher Corporation 11.5 Merck KGAA 11.6 Parker Hannifin Corporation 11.7 Rad Source Technologies, Inc. 11.8 SGS SA 11.9 Sartorius AG 11.10 Texcell, Inc. 11.11 Viral Inactivated Plasma Systems SA 11.12 Wuxi Pharmatech (Cayman) Inc. 11.13 Shandong Weigao Group Medical Polymer Company Limited 11.14 Cerus Corporation 11.15 Terumo BCT, Inc. 11.16 BioReliance 11.17 Thermo Fisher Scientific Inc. 11.18 Macopharma SA List of Tables Table 1 Global Viral Inactivation Market Outlook, By Region (2014-2023) ($MN) Table 2 Global Viral Inactivation Market Outlook, By Application (2014-2023) ($MN) Table 3 Global Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN) Table 4 Global Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN) Table 5 Global Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN) Table 6 Global Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN) Table 7 Global Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN) Table 8 Global Viral Inactivation Market Outlook, By Product (2014-2023) ($MN) Table 9 Global Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN) Table 10 Global Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN) Table 11 Global Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN) Table 12 Global Viral Inactivation Market Outlook, By Method (2014-2023) ($MN) Table 13 Global Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN) Table 14 Global Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN) Table 15 Global Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN) Table 16 Global Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN) Table 17 Global Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN) Table 18 Global Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN) Table 19 Global Viral Inactivation Market Outlook, By End User (2014-2023) ($MN) Table 20 Global Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN) Table 21 Global Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN) Table 22 Global Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN) Table 23 Global Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN) Table 24 Global Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN) Table 25 North America Viral Inactivation Market Outlook, By Country (2014-2023) ($MN) Table 26 North America Viral Inactivation Market Outlook, By Application (2014-2023) ($MN) Table 27 North America Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN) Table 28 North America Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN) Table 29 North America Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN) Table 30 North America Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN) Table 31 North America Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN) Table 32 North America Viral Inactivation Market Outlook, By Product (2014-2023) ($MN) Table 33 North America Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN) Table 34 North America Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN) Table 35 North America Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN) Table 36 North America Viral Inactivation Market Outlook, By Method (2014-2023) ($MN) Table 37 North America Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN) Table 38 North America Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN) Table 39 North America Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN) Table 40 North America Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN) Table 41 North America Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN) Table 42 North America Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN) Table 43 North America Viral Inactivation Market Outlook, By End User (2014-2023) ($MN) Table 44 North America Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN) Table 45 North America Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN) Table 46 North America Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN) Table 47 North America Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN) Table 48 North America Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN) Table 49 Europe Viral Inactivation Market Outlook, By Country (2014-2023) ($MN) Table 50 Europe Viral Inactivation Market Outlook, By Application (2014-2023) ($MN) Table 51 Europe Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN) Table 52 Europe Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN) Table 53 Europe Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN) Table 54 Europe Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN) Table 55 Europe Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN) Table 56 Europe Viral Inactivation Market Outlook, By Product (2014-2023) ($MN) Table 57 Europe Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN) Table 58 Europe Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN) Table 59 Europe Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN) Table 60 Europe Viral Inactivation Market Outlook, By Method (2014-2023) ($MN) Table 61 Europe Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN) Table 62 Europe Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN) Table 63 Europe Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN) Table 64 Europe Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN) Table 65 Europe Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN) Table 66 Europe Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN) Table 67 Europe Viral Inactivation Market Outlook, By End User (2014-2023) ($MN) Table 68 Europe Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN) Table 69 Europe Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN) Table 70 Europe Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN) Table 71 Europe Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN) Table 72 Europe Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN) Table 73 Asia Pacific Viral Inactivation Market Outlook, By Country (2014-2023) ($MN) Table 74 Asia Pacific Viral Inactivation Market Outlook, By Application (2014-2023) ($MN) Table 75 Asia Pacific Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN) Table 76 Asia Pacific Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN) Table 77 Asia Pacific Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN) Table 78 Asia Pacific Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN) Table 79 Asia Pacific Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN) Table 80 Asia Pacific Viral Inactivation Market Outlook, By Product (2014-2023) ($MN) Table 81 Asia Pacific Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN) Table 82 Asia Pacific Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN) Table 83 Asia Pacific Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN) Table 84 Asia Pacific Viral Inactivation Market Outlook, By Method (2014-2023) ($MN) Table 85 Asia Pacific Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN) Table 86 Asia Pacific Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN) Table 87 Asia Pacific Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN) Table 88 Asia Pacific Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN) Table 89 Asia Pacific Viral Inactivation Market Outlook, By High-energy light (2014-2023) ($MN) Table 90 Asia Pacific Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN) Table 91 Asia Pacific Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN) Table 92 Asia Pacific Viral Inactivation Market Outlook, By End User (2014-2023) ($MN) Table 93 Asia Pacific Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN) Table 94 Asia Pacific Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN) Table 95 Asia Pacific Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN) Table 96 Asia Pacific Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN) Table 97 Asia Pacific Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN) Table 98 South America Viral Inactivation Market Outlook, By Country (2014-2023) ($MN) Table 99 South America Viral Inactivation Market Outlook, By Application (2014-2023) ($MN) Table 100 South America Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN) Table 101 South America Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN) Table 102 South America Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN) Table 103 South America Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN) Table 104 South America Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN) Table 105 South America Viral Inactivation Market Outlook, By Product (2014-2023) ($MN) Table 106 South America Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN) Table 107 South America Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN) Table 108 South America Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN) Table 109 South America Viral Inactivation Market Outlook, By Method (2014-2023) ($MN) Table 110 South America Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN) Table 111 South America Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN) Table 112 South America Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN) Table 113 South America Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN) Table 114 South America Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN) Table 115 South America Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN) Table 116 South America Viral Inactivation Market Outlook, By End User (2014-2023) ($MN) Table 117 South America Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN) Table 118 South America Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN) Table 119 South America Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN) Table 120 South America Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN) Table 121 South America Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN) Table 122 Middle East & Africa Viral Inactivation Market Outlook, By Country (2014-2023) ($MN) Table 123 Middle East & Africa Viral Inactivation Market Outlook, By Application (2014-2023) ($MN) Table 124 Middle East & Africa Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN) Table 125 Middle East & Africa Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN) Table 126 Middle East & Africa Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN) Table 127 Middle East & Africa Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN) Table 128 Middle East & Africa Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN) Table 129 Middle East & Africa Viral Inactivation Market Outlook, By Product (2014-2023) ($MN) Table 130 Middle East & Africa Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN) Table 131 Middle East & Africa Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN) Table 132 Middle East & Africa Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN) Table 133 Middle East & Africa Viral Inactivation Market Outlook, By Method (2014-2023) ($MN) Table 134 Middle East & Africa Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN) Table 135 Middle East & Africa Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN) Table 136 Middle East & Africa Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN) Table 137 Middle East & Africa Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN) Table 138 Middle East & Africa Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN) Table 139 Middle East & Africa Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN) Table 140 Middle East & Africa Viral Inactivation Market Outlook, By End User (2014-2023) ($MN) Table 141 Middle East & Africa Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN) Table 142 Middle East & Africa Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN) Table 143 Middle East & Africa Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN) Table 144 Middle East & Africa Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN) Table 145 Middle East & Africa Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN)
  • PRICE
  • $4150
    $7500

Our Clients